Psilocybin may leave lasting molecular changes in the brain as a new study links psychedelic exposure to altered gene expression in neurons and support cells

Psilocybin may trigger lasting molecular changes in the brain beyond the acute trip, with new evidence pointing to altered gene expression in neurons and glial cells after psychedelic exposure. The central clue is that a brief experience could set off longer biological processes tied to plasticity, mood, and perception. The reported findings connect psychedelic effects to changes in how brain cells regulate genes rather than only to short-lived receptor activity. That matters because durable shifts in cellular programs could help explain why some therapeutic benefits outlast the drug's presence in the body. The broader implication is that psychedelic research is moving from questions about subjective experience alone toward measurable mechanisms in brain tissue. If replicated and clarified, those mechanisms could shape how scientists understand antidepressant effects, treatment timing, and the risks or limits of trying to induce plasticity pharmacologically.